CD4-selective targeting of an antibody-polycation-DNA complex was investiga
ted The complex was synthesized with the anti-CD4 monoclonal antibody B-F5,
polylysine(268) (pLL) and either the pGL3 control vector containing the lu
ciferase reporter gene or the pGeneGrip vector containing the green fluores
cent protein (GFP) gene. B-F5-pLL-DNA complexes inhibited the binding of I-
125-B-F5 to CD4(+) Jurkat cells, while complexes synthesised either without
B-F5 or using a non-specific mouse IgG1 antibody had little or no effect E
xpression of the luciferase reporter gene was achieved in Jurkat cells usin
g the B-F5-pLL-pGL3 complex and was enhanced in the presence of PMA. Neglig
ible luciferase activity was defected with the non-specific antibody comple
x in Jurkat cells or with the B-F5-pLL-pGL3 complex in the CD4(-) K-562 cel
ls. Using complexes synthesised with the pGeneGrip vector, the transfection
efficiency in Jurkat and K-562 cells was examined using confocal microscop
y. More than 95% of Jurkat cells expressed GFP and the level of this expres
sion was markedly enhanced by PMA. Negligible GFP expression was seen in K-
562 cells or when B-F5 was replaced by a nonspecific antibody. Using flow c
ytometry, fluorescein-labelled complex showed specific targeting to CD4(+)
cells in a mixed cell population from human peripheral blood. These studies
demonstrate the selective transfection of CD4(+) T-lymphoid cells using a
polycation-based gene delivery system. The complex may provide a means of d
elivering anti-HIV gene therapies to CD4(+) cells in vivo.